NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Arpeggio Biosciences

Arpeggio Biosciences

Private
Boulder, ColoradoHealthcare & Life Scienceshttps://www.arpeggiobio.com/

Last Round

Series B

Nov 25, 2025

Est. Valuation

$2.14M

Total Funding Raised

$24.38M

Company Overview

Arpeggio Biosciences is a biotechnology company that develops a drug assessment technology platform combining proprietary biological assays and machine learning to provide insights into cellular dynamics and identify new drug targets.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

transcriptomicsdrug discoveryRNA sequencingAI drug discoverytoxicity profilingmechanism of actiongene expression analysisin silico drug designbiotech platformdrug pipeline developmentnascent-RNA sequencingAI-native biotechcomputational biologybiological intelligencedrug discovery services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arpeggio Biosciences Comparables

Compare Arpeggio Biosciences with similar companies based on industry and business-model similarity.

Arpeggio Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Transcripta Bio
84%
Phenomic AI
79%
Alithea Genomics
77%

Arpeggio Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 25, 2025
Series A ExtensionJan 30, 2024
Series ASep 7, 2022
SeedJan 15, 2020
AcceleratorAug 16, 2019

Key People

Founding team and executive leadership

Joey Azofeifa

CEO Co-founder

Founding Team

Tim Read

Chief Technology Officer

Executive Team

Arpeggio Biosciences Investors

Notable investors and investment history

Arpeggio Biosciences investors
InvestorRounds
Builders VCSeries A
Khosla VenturesSeries A, Seed
Tau VenturesSeries A
BoxOne VenturesSeries A
Y CombinatorSeed, Accelerator
FundersClubSeries A, Seed
ATEM CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 15, 2020

    $3.2M round led by Khosla Ventures

Arpeggio Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arpeggio Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arpeggio Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoulder, Colorado
Employee Range17
Year Founded2017
Last FundingNov 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.